Literature DB >> 7295334

Restored in vitro sensitivity of adriamycin- and vincristine-resistant P388 leukemia with reserpine.

M Inaba, R Fujikura, S Tsukagoshi, Y Sakurai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7295334     DOI： 10.1016/0006-2952(81)90246-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  14 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Verapamil enhanced in vitro chemosensitivity of a murine bladder carcinoma, FCB.

Authors:  R J Ballou; W G Simpson; J I Harty; M T Tseng
Journal:  Urol Res       Date:  1986

Review 3.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

Review 4.  Tumour cell resistance to anthracyclines--a review.

Authors:  S Kaye; S Merry
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Modulation of drug cytotoxicity in wild-type and multidrug-resistant tumor cells by stereoisomeric series of C-20'-vinblastine congeners that lack antimicrotubule activity.

Authors:  L S Borman; W G Bornmann; M E Kuehne
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Decreased retention of vinca alkaloids in chronic lymphatic leukemia cells from refractory patients.

Authors:  M Beksac; C Peterson; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancer.

Authors:  G T Budd; R M Bukowski; A Lichtin; L Bauer; P Van Kirk; R Ganapathi
Journal:  Invest New Drugs       Date:  1993-02       Impact factor: 3.850

8.  Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein.

Authors:  S P Cole; H F Downes; M L Slovak
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

9.  Reversion of p-glycoprotein-mediated multidrug resistance in human leukemic cell line by diallyl trisulfide.

Authors:  Qing Xia; Zhi-Yong Wang; Hui-Qing Li; Yu-Tao Diao; Xiao-Li Li; Jia Cui; Xue-Liang Chen; Hao Li
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-12       Impact factor: 2.629

10.  Cross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line.

Authors:  R S Gupta; W Murray; R Gupta
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.